Insider · CIK 0001799081

Taylor Stacy L

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001799081

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-22	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−26.9K sh	$4.50	−$121K	139,365
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−6,772 sh	$3.43	−$23.2K	172,896
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−6,609 sh	$3.44	−$22.7K	166,287
2024-03-04	ADPTAdaptive Biotechnologies CorpA Award	SVP and General Counsel	AAward	+40K sh	—	—	179,668
2024-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+60K sh	—	—	60,010
2023-03-07	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−13.4K sh	$8.60	−$115K	139,678
2023-03-06	ADPTAdaptive Biotechnologies CorpA Award	SVP and General Counsel	AAward	+85.7K sh	—	—	158,556
2023-03-06	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−5,491 sh	$8.57	−$47.1K	153,065
2023-03-06	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	SVP and General Counsel	AAward	+129K sh	—	—	128,599
2022-03-08	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−2,387 sh	$11.44	−$27.3K	72,859
2022-03-07	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−1,569 sh	$12.01	−$18.8K	75,246
2022-03-04	ADPTAdaptive Biotechnologies CorpA Award	SVP and General Counsel	AAward	+61.8K sh	—	—	76,815
2022-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	SVP and General Counsel	AAward	+154K sh	—	—	154,448
2021-12-22	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+10.1K sh	$6.55	+$66.4K	25,166
2021-12-22	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+5,208 sh	$7.80	+$40.6K	30,374
2021-12-22	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−15.3K sh	$30.00	−$460K	15,036
2021-12-22	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−10.1K sh	—	—	5,313
2021-12-22	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−5,208 sh	—	—	17,709
2021-09-07	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+495 sh	$6.55	+$3,242.25	15,531
2021-09-07	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−495 sh	$40.00	−$19.8K	15,036
2021-09-07	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−495 sh	—	—	15,443
2021-06-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,042 sh	$7.80	+$8,127.6	16,078
2021-06-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,771 sh	$6.55	+$11.6K	17,849
2021-06-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,354 sh	$31.71	+$42.9K	19,203
2021-06-30	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−3,772 sh	$41.35	−$156K	15,431
2021-06-30	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−395 sh	$42.13	−$16.6K	15,036
2021-06-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,042 sh	—	—	22,917
2021-06-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,771 sh	—	—	15,938
2021-06-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,354 sh	—	—	43,334
2021-06-17	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,041 sh	$7.80	+$8,119.8	16,077
2021-06-17	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,771 sh	$6.55	+$11.6K	17,848
2021-06-17	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,354 sh	$31.71	+$42.9K	19,202
2021-06-17	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−4,166 sh	$40.00	−$167K	15,036
2021-06-17	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,041 sh	—	—	23,959
2021-06-17	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,771 sh	—	—	17,709
2021-06-17	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,354 sh	—	—	44,688
2021-04-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,042 sh	$7.80	+$8,127.6	16,078
2021-04-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,770 sh	$6.55	+$11.6K	17,848
2021-04-30	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,354 sh	$31.71	+$42.9K	19,202
2021-04-30	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−4,166 sh	$41.93	−$175K	15,036
2021-04-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,042 sh	—	—	25,000
2021-04-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,770 sh	—	—	19,480
2021-04-30	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,354 sh	—	—	46,042
2021-03-31	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,042 sh	$7.80	+$8,127.6	16,078
2021-03-31	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,771 sh	$6.55	+$11.6K	17,849
2021-03-31	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	+1,354 sh	$31.71	+$42.9K	19,203
2021-03-31	ADPTAdaptive Biotechnologies CorpS Sale	SVP and General Counsel	SSale	−4,167 sh	$40.00	−$167K	15,036
2021-03-31	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,042 sh	—	—	26,042
2021-03-31	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,771 sh	—	—	21,250
2021-03-31	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	SVP and General Counsel	MExercise/Conversion	−1,354 sh	—	—	47,396

Recent filings

Accepted (ET)
Aug 234
Taylor Stacy L0001062993-24-015606
SEC(opens sec.gov)
Mar 64
Taylor Stacy L0001062993-24-005766
SEC(opens sec.gov)
Mar 84
Taylor Stacy L0001062993-23-006328
SEC(opens sec.gov)
Mar 104
Taylor Stacy L0001209191-22-018095
SEC(opens sec.gov)
Mar 84
Taylor Stacy L0001209191-22-017397
SEC(opens sec.gov)
Dec 234
Taylor Stacy L0001209191-21-071194
SEC(opens sec.gov)
Sep 94
Taylor Stacy L0001209191-21-055367
SEC(opens sec.gov)

Companies

Adaptive Biotechnologies CorpSVP and General CounselADPT

Address

C/O ADAPTIVE BIOTECHNOLOGIES 1551 EASTLAKE AVE E STE 200

SEATTLE, WA, 98102